Medtronic 8-K Details Financials, Officer Changes, and Debt Structure
Ticker: MDT · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, debt, financial-condition, officer-changes
TL;DR
**Medtronic just dropped an 8-K covering financials, officer changes, and its debt profile, so keep an eye on those senior notes.**
AI Summary
Medtronic plc filed an 8-K on February 20, 2024, reporting its financial condition and results of operations as of February 13, 2024. The filing also detailed compensatory arrangements for certain officers and the departure or election of directors. Key financial instruments mentioned include various senior notes due between 2025 and 2031, indicating ongoing debt management.
Why It Matters
This filing provides investors with an updated snapshot of Medtronic's financial health and leadership, crucial for assessing the company's stability and future direction.
Risk Assessment
Risk Level: low — The 8-K is a routine disclosure of financial condition and corporate governance changes, not indicating immediate high risk.
Key Players & Entities
- Medtronic plc (company) — Filer of the 8-K
- February 13, 2024 (date) — Conformed period of report
- February 20, 2024 (date) — Filed as of date
- Senior Notes 2019 Due 2025 (dollar_amount) — Financial instrument
- Senior Notes 2020 Due 2025 (dollar_amount) — Financial instrument
- Senior Notes 2022 Due 2025 (dollar_amount) — Financial instrument
- Senior Notes 2019 Due 2027 (dollar_amount) — Financial instrument
- Senior Notes 2020 Due 2028 (dollar_amount) — Financial instrument
- Senior Notes 2022 Due 2028 (dollar_amount) — Financial instrument
- Senior Notes 2019 Due 2031 (dollar_amount) — Financial instrument
FAQ
What is the purpose of Medtronic plc's 8-K filing on February 20, 2024?
The 8-K filing by Medtronic plc on February 20, 2024, reports on the company's results of operations and financial condition, details the departure or election of directors and appointment of certain officers, and outlines compensatory arrangements for certain officers, as well as financial statements and exhibits.
What specific financial instruments are mentioned in the filing as of February 13, 2024?
The filing specifically mentions various senior notes, including 'Senior Notes 2019 Due 2025', 'Senior Notes 2020 Due 2025', 'Senior Notes 2022 Due 2025', 'Senior Notes 2019 Due 2027', 'Senior Notes 2020 Due 2028', 'Senior Notes 2022 Due 2028', and 'Senior Notes 2019 Due 2031'.
When was the conformed period of report for this 8-K filing?
The conformed period of report for this 8-K filing was February 13, 2024.
What type of industry does Medtronic plc belong to according to its SIC code?
According to its Standard Industrial Classification (SIC), Medtronic plc belongs to the 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]' industry.
What items of information are included in this 8-K filing?
The 8-K filing includes 'Results of Operations and Financial Condition', 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', and 'Financial Statements and Exhibits'.
Filing Stats: 787 words · 3 min read · ~3 pages · Grade level 9.8 · Accepted 2024-02-20 06:47:01
Key Financial Figures
- $0.0001 — registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange
Filing Documents
- mdt-20240213.htm (8-K) — 61KB
- exhibit991-fy24q3earningsr.htm (EX-99) — 891KB
- image_0.jpg (GRAPHIC) — 25KB
- 0001613103-24-000006.txt ( ) — 1299KB
- mdt-20240213.xsd (EX-101.SCH) — 6KB
- mdt-20240213_def.xml (EX-101.DEF) — 22KB
- mdt-20240213_lab.xml (EX-101.LAB) — 51KB
- mdt-20240213_pre.xml (EX-101.PRE) — 24KB
- mdt-20240213_htm.xml (XML) — 15KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On February 20, 2024, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its third quarter fiscal year 2024 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As referenced in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K, the Company announced on February 20, 2024 its decision to wind down and exit the ventilator business and combine the remaining businesses within its Patient Monitoring and Respiratory Interventions operating units into a single operating unit. These operational changes will result in the elimination of the position of Executive Vice President and President of Medtronic's Medical Surgical Portfolio, currently held by Robert J. White. Mr. White will leave the Company effective April 26, 2024, and because Mr. White's separation from Medtronic constitutes a termination without cause, Mr. White will receive severance payments and benefits consistent with Medtronic's severance practices for executive officers, as described in Medtronic's 2023 Proxy Statement filed with the Securities and Exchange Commission on August 11, 2023.
01. Exhibits
Item 9.01. Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc, dated February 2 0 , 202 4 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Karen L. Parkhill Date: February 20, 2024 Karen L. Parkhill Executive Vice President and Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press release of Medtronic plc, dated February 20, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).